BIOMAT Database Logo BIOMAT Database Logo

Circulating Melanoma Cell Subpopulations: Their Heterogeneity and Differential Responses to Treatment. 2015

Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
School of Medical Sciences, Edith Cowan University, Perth, Washington, Australia. Electronic address: e.gray@ecu.edu.au.

Metastatic melanoma is a highly heterogeneous tumor; thus, methods to analyze tumor-derived cells circulating in blood should address this diversity. Taking this into account, we analyzed, using multiparametric flow cytometry, the co-expression of the melanoma markers melanoma cell adhesion molecule and melanoma-associated chondroitin sulphate proteoglycan and the tumor-initiating markers ATP-binding cassette sub-family B member 5 (ABCB5), CD271, and receptor activator of NF-κβ (RANK) in individual circulating tumor cells (CTCs) from 40 late-stage (III-IV) and 16 early-stage (I-II) melanoma patients. CTCs were heterogeneous within and between patients, with limited co-expression between the five markers analyzed. Analysis of patient matched blood and metastatic tumors revealed that ABCB5 and RANK subpopulations are more common among CTCs than in the solid tumors, suggesting a preferential selection for these cells in circulation. Pairwise comparison of CTC subpopulations longitudinally before and 6-13 weeks after treatment initiation showed that the percentage of RANK(+) CTCs significantly increased in the patients undergoing targeted therapy (N=16, P<0.01). Moreover, the presence of ⩾5 RANK(+) CTCs in the blood of patients undergoing targeted therapies was prognostic of shorter progression-free survival (hazards ratio 8.73, 95% confidence interval 1.82-41.75, P<0.01). Taken together, our results provide evidence of the heterogeneity among CTC subpopulations in melanoma and the differential response of these subpopulations to targeted therapy.

UI MeSH Term Description Entries
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009360 Neoplastic Cells, Circulating Exfoliate neoplastic cells circulating in the blood and associated with metastasizing tumors. Circulating Neoplastic Cells,Embolic Tumor Cells,Embolism, Tumor,Neoplasm Circulating Cells,Tumor Cells, Embolic,Cells, Neoplasm Circulating,Circulating Cells, Neoplasm,Circulating Tumor Cells,Cell, Circulating Neoplastic,Cell, Circulating Tumor,Cell, Embolic Tumor,Cell, Neoplasm Circulating,Cells, Circulating Neoplastic,Cells, Circulating Tumor,Cells, Embolic Tumor,Circulating Neoplastic Cell,Circulating Tumor Cell,Embolic Tumor Cell,Embolisms, Tumor,Neoplasm Circulating Cell,Neoplastic Cell, Circulating,Tumor Cell, Circulating,Tumor Cell, Embolic,Tumor Cells, Circulating,Tumor Embolism,Tumor Embolisms
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D011508 Chondroitin Sulfate Proteoglycans Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains. Proteochondroitin Sulfates,Chondroitin Sulfate Proteoglycan,Proteochondroitin Sulfate,Proteoglycan, Chondroitin Sulfate,Proteoglycans, Chondroitin Sulfate,Sulfate Proteoglycan, Chondroitin,Sulfate Proteoglycans, Chondroitin

Related Publications

Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
August 1976, Journal of the National Cancer Institute,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Heterogeneity of Circulating Tumor Cell Neoplastic Subpopulations Outlined by Single-Cell Transcriptomics.
September 2021, Cancers,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma.
January 2017, NPJ genomic medicine,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Heterogeneity of human T lymphocytes to bind sheep erythrocytes and mitogenic responses of their subpopulations.
December 1975, Journal of immunology (Baltimore, Md. : 1950),
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Differential responses to mutagens among human lymphocyte subpopulations.
January 2009, Mutation research,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.
April 2014, Seminars in oncology,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Linking differential radiation responses to glioma heterogeneity.
March 2014, Oncotarget,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Heterogeneity of Melanoma Cell Responses to Sleep Apnea-Derived Plasma Exosomes and to Intermittent Hypoxia.
September 2021, Cancers,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Molecular characterization of prohibitins and their differential responses to WSSV infection in hemocyte subpopulations of Fenneropenaeus chinensis.
November 2020, Fish & shellfish immunology,
Elin S Gray, and Anna L Reid, and Samantha Bowyer, and Leslie Calapre, and Kelvin Siew, and Robert Pearce, and Lester Cowell, and Markus H Frank, and Michael Millward, and Mel Ziman
Quantifying Cell Heterogeneity and Subpopulations Using Single Cell Metabolomics.
May 2023, Analytical chemistry,
Copied contents to your clipboard!